Skip to main content

Author: Leigh MacMillan

Alzheimer’s risk gene in younger adults

Jun. 2, 2016—A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age.

Read more


Promise of discovery drives Biomedical Sciences graduates

May. 19, 2016—In a twist on the usual research narrative, Justin Siemann, Ph.D., who celebrated his doctoral degree in Neuroscience at last week’s Graduate School Commencement, conducted research on patients first, and then moved to the laboratory bench.

Read more


Current cancer drug discovery method flawed: VUMC study

May. 5, 2016—The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.

Read more


Drug combos for glioblastoma

May. 3, 2016—Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment.

Read more


Investigators explore African ancestry, Alzheimer’s risk

Apr. 28, 2016—Higher genomic levels of African ancestry are associated with an increased risk for Alzheimer’s disease, a consortium of investigators reported recently in Alzheimer’s & Dementia.

Read more


Cancer expert Thompson to deliver May 5 Flexner Discovery Lecture

Apr. 28, 2016—Craig Thompson, M.D., president and CEO of Memorial Sloan Kettering Cancer Center, will deliver the next Flexner Discovery Lecture on May 5.

Read more


Nobel laureate Betzig set for Discovery Lecture

Apr. 21, 2016—Eric Betzig, Ph.D., who shared the 2014 Nobel Prize in Chemistry for the development of super-resolved fluorescence microscopy, will deliver the next Flexner Discovery Lecture on April 28.

Read more


Myelin repair factors

Apr. 19, 2016—Vanderbilt researchers show that two factors promote the repair of myelin, the nerve cell covering that deteriorates in diseases such as multiple sclerosis.

Read more


Immune defenses in asthma

Apr. 5, 2016—Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.

Read more


New treatment for Crohn’s disease

Mar. 22, 2016—A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.

Read more


Fat hormone’s role in zebrafish

Mar. 8, 2016—The hormone leptin regulates glucose balance, but not fat stores, in zebrafish.

Read more


Melanoma response to immune therapy

Mar. 3, 2016—Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy.

Read more


Upcoming Events

MORE EVENTS »